- Home
- SHFS vs QNRX Comparison
SHFS vs QNRX Comparison
Compare SHFS & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHFS
- QNRX
- Stock Information
- Founded
- SHFS 2015
- QNRX 2018
- Country
- SHFS United States
- QNRX United States
- Employees
- SHFS N/A
- QNRX N/A
- Industry
- SHFS Finance: Consumer Services
- QNRX Medical/Dental Instruments
- Sector
- SHFS Finance
- QNRX Health Care
- Exchange
- SHFS Nasdaq
- QNRX Nasdaq
- Market Cap
- SHFS 6.2M
- QNRX 5.5M
- IPO Year
- SHFS N/A
- QNRX N/A
- Fundamental
- Price
- SHFS $3.27
- QNRX $8.89
- Analyst Decision
- SHFS
- QNRX
- Analyst Count
- SHFS 0
- QNRX 0
- Target Price
- SHFS N/A
- QNRX N/A
- AVG Volume (30 Days)
- SHFS 36.3K
- QNRX 8.2K
- Earning Date
- SHFS 08-13-2025
- QNRX 08-07-2025
- Dividend Yield
- SHFS N/A
- QNRX N/A
- EPS Growth
- SHFS N/A
- QNRX N/A
- EPS
- SHFS N/A
- QNRX N/A
- Revenue
- SHFS $13,956,453.00
- QNRX N/A
- Revenue This Year
- SHFS N/A
- QNRX N/A
- Revenue Next Year
- SHFS N/A
- QNRX N/A
- P/E Ratio
- SHFS N/A
- QNRX N/A
- Revenue Growth
- SHFS N/A
- QNRX N/A
- 52 Week Low
- SHFS $1.84
- QNRX $5.01
- 52 Week High
- SHFS $14.86
- QNRX $54.95
- Technical
- Relative Strength Index (RSI)
- SHFS 63.00
- QNRX 51.38
- Support Level
- SHFS $2.14
- QNRX $8.60
- Resistance Level
- SHFS $3.87
- QNRX $9.40
- Average True Range (ATR)
- SHFS 0.31
- QNRX 0.50
- MACD
- SHFS 0.11
- QNRX -0.05
- Stochastic Oscillator
- SHFS 57.72
- QNRX 46.11
About SHFS SHF Holdings Inc.
SHF Holdings Inc is a financial services provider to cannabis-related businesses. It offers reliable access to banking solutions for cannabis, hemp, CBD, and ancillary operators, making communities safer, driving growth in local economies, and fostering long-term partnerships. The group, through its financial institution clients, implements accountability, transparency, monitoring, reporting, and risk mitigation measures while meeting Bank Secrecy Act obligations in line with FinCEN guidance on cannabis-related businesses. Its services include Program Management Support, Customer Generation, Ongoing Program Auditing, and Compliance Monitoring, among others.
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.